French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

• Status: Completed
• Trial end date: 2011-11-28
• Target enrollment: 0
• Participant gender: All

Summary

This study is conducted in Europe. The aim of this study is to extract data from the French National Registry holding information about patients having initiated growth hormone therapy with the objective to describe patients receiving growth hormone therapy, assess efficacy and safety of somatropin (Norditropin® SimpleXx®) and evaluate treatment compliance.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Hormones

Criteria

Inclusion Criteria:

• Adult with growth hormone deficiency

• Treated with Norditropin® SimpleXx (somatropin)